Remus Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 70.95% of Remus Pharmaceuticals, FIIs hold 5.10%, DIIs hold 0.43% and the public holds 23.52%. Promoter holding was unchanged from Mar 2026.
Get an alert when Remus Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
70.95%
unchanged QoQ
FIIs
5.10%
−0.18 pp QoQ
DIIs
0.43%
−0.40 pp QoQ
Public
23.52%
+0.59 pp QoQ
Remus Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 70.95% | 5.10% | 0.43% | 23.52% | 2,092 |
| Mar 2026 | 70.95% | 5.28% | 0.83% | 22.93% | 2,009 |
| Sep 2025 | 70.91% | 5.02% | 0.77% | 23.31% | 2,032 |
| Mar 2025 | 70.85% | 4.77% | 0.77% | 23.60% | 1,878 |
| Sep 2024 | 70.84% | 3.16% | 0.77% | 25.22% | 1,753 |
| Jun 2024 | 70.66% | 3.00% | 0.73% | 25.61% | 1,577 |
| Mar 2024 | 70.60% | 3.25% | 0.67% | 25.49% | 1,124 |
| Sep 2023 | 69.61% | 2.38% | 0.71% | 27.30% | 856 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹956 cr, the promoter group's 70.95% stake is worth ₹678 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Remus Pharmaceuticals shareholding: common questions
What is the promoter holding in Remus Pharmaceuticals?
Promoters hold 70.95% of Remus Pharmaceuticals as of Sep 2026. Their stake was unchanged from Mar 2026.
How much do FIIs hold in Remus Pharmaceuticals?
Foreign institutional investors (FIIs) held 5.10% of Remus Pharmaceuticals in Sep 2026, −0.18 pp versus Mar 2026.
How much do mutual funds and other DIIs hold in Remus Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 0.43% of Remus Pharmaceuticals in Sep 2026, −0.40 pp versus Mar 2026.
Is the promoter holding in Remus Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Remus Pharmaceuticals.
How has Remus Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 70.84% in Sep 2024 to 70.95% in Sep 2026 (+0.11 pp).
How many shareholders does Remus Pharmaceuticals have?
Remus Pharmaceuticals had 2,092 shareholders in Sep 2026, compared with 2,009 in Mar 2026.